basmisanil: Clinical Trials

2 completed, 2 terminated, 1 not yet recruiting. 4 Phase 2, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	4	Terminated 2, Completed 1, Not yet recruiting 1
Phase 1	1	Completed 1

Follow basmisanil: new trials by email Literature Review of basmisanil trials Research Report on basmisanil

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Phase II Study of Basmisanil in Children and Adolescents With Dup15q Syndrome Basmisanil, Placebo - Dup15Q Syndrome	Phase 2	Not yet recruiting	Newleos Therapeutics, Inc.	30	2026-12-01	2026-09-29
A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome Basmisanil, Placebo - Dup15q Syndrome	Phase 2	Terminated	Hoffmann-La Roche	7	2022-12-16	2026-08-18
A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke Basmisanil, Placebo - Stroke	Phase 2	Terminated	Hoffmann-La Roche	5	2017-02-20	2019-01-02
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics Basmisanil, Placebo - Schizophrenia	Phase 2	Completed	Hoffmann-La Roche	214	2016-11-30	2021-02-09
Basmisanil Positron Emission Tomography Study in Japanese Volunteers Basmisanil - Healthy Volunteer	Phase 1	Completed	Hoffmann-La Roche	6	2015-08-01	2017-01-26

Conditions studied

Chromosome 15q, trisomy (1)  ·  Infarction, Middle Cerebral Artery (1)  ·  Polyposis Syndrome, Hereditary Mixed, 1 (1)  ·  Schizophrenia (1)  ·  Stroke (1)

Sponsors

Hoffmann-La Roche (4)  ·  Newleos Therapeutics, Inc. (1)

Countries

United States (3)  ·  Spain (2)  ·  United Kingdom (2)  ·  France (1)

Results publications

PMID 41983730

NIH funding

2015 (2)